the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Ahmad Zahid hopes TVET remains top choice for further education

KUALA PILAH: Deputy Prime Minister Datuk Seri Dr Ahmad Zahid Hamidi has expressed hope that the Technical and Vocational Education and Training (TVET) will continue to be a preferred pathway for advancing education to higher levels, particularly for students who did not attain satisfactory results in the Sijil Pelajaran Malaysia (SPM).

The Minister of Rural and Regional Development highlighted that many countries like Japan and China also viewed TVET as a primary education system offering extensive career opportunities in the future, particularly for young people.

“Many investors, both local and foreign, require engineers and technical professionals. Where else can we find such skilled workforce if not through TVET? That’s why we’ve established numerous TVET institutions nationwide.

“It also proves that through TVET, one can pursue education up to the doctoral level,“ he said when launching the Kuala Pilah UMNO Division meeting attended by over 700 representatives from 126 branches here today.

He mentioned that the employment rate for TVET graduates was high, reaching 94.5 per cent.

In addition, Ahmad Zahid said that Tahfiz students were also offered opportunities to continue their education in TVET to enable them to secure jobs in technical or engineering fields while further strengthening their religious education.

He added that 200 spots out of 5,125 quotas for short and medium-term TVET training courses in China were offered to the Negeri Sembilan youths.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings